Clinical Trial Update: Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing argatroban combined with antiplatelet therapy vs antiplatelet therapy alone for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke Ischemic

Drugs mentioned

• Antiplatelet therapy (antiplatelet agents)
• Argatroban (argatroban)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Stroke, Ischemic | Phase 4 | Status: COMPLETED